BRAEBURN INC.

BRIXADI

Manufacturer:

BRAEBURN INC.

Brixadi HCPCS:

J0576

HCPCS Code Descriptor:

Injection, buprenorphine extended-release (brixadi), 1 mg

Category:

J Code

Brixadi NDCs:

58284-0228-01, 58284-0264-01, 58284-0296-01, 58284-0208-01, 58284-0232-01, 58284-0224-01, 58284-0216-01

Primary Type:

Opioid Analgesic

Generic/Specialty Status:

Single-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Brixadi:

BRIXADI is a Opioid Analgesic drug manufactured by BRAEBURN INC. and administered via the Subcutaneous route of administration. The J Code: J0576 is aligned to the drug BRIXADI.

ACCESS PRICING AND MORE BY REGISTERING

J0576 Added Date:

January 1, 2024

J0576 Effective Date:

January 1, 2024

J0576 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Brixadi billing and coding information.
Brixadi patient assistance information can be found through Braeburn Pharmaceuticals at the URL: https://www.brixadi.com/
BRIXADI prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for BRIXADI. Please check back in a few weeks.